Maria Paula Foss

Maria Paula Foss

Auto-generated profile, based on publicly available information

Maria Paula Foss

Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
MFMaria Paula Foss
Maria Paula Foss
VCViviane Amaral de Carvalho
Viviane Amaral de Carvalho
TMThais Helena Machado
Thais Helena Machado
GRGeraldo Cássio dos Reis
Geraldo Cássio dos Reis
VTVitor Tumas
Vitor Tumas
CPCláudia Sellitto Porto
Cláudia Sellitto Porto
Objective: To expand norms for the Mattis Dementia Rating Scale (DRS) for the Brazilian middle-age and elderly populations. Methods: The DRS was administered to 502 individuals without cognitive deficits, 312 women and 190 men, aged 50 years or over and with educational level ranging from 0 to 13 years or more. The sample was composed of subjects who participated in other studies, from Caeté (Minas Gerais state), Ribeirão Preto (São Paulo state) and São Paulo (São Paulo state). Participants were divided into four schooling groups (illiterate, 1 to 4 years, 5 to 12 years and 13 years or more). The subjects were divided into four groups according to age (50 to 60, 61 to 70, 71 to 80, and 80 years or over). Results: Normative data for DRS scores are expressed as percentile values. The group with lowest schooling and subjects older than 80 years had the worst scores. Conclusion: As expected, age and education were strongly correlated with DRS scores. Illiterates and older old individuals performed worse than the other groups. These data might help to improve the accuracy of the diagnosis of cognitive impairment and dementia in Brazilian middle-age and elderly populations.

5 March 2016 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
CSCarolina Pinto Souza
Carolina Pinto Souza
GOGuiomar Nascimento Oliveira
Guiomar Nascimento Oliveira
MFMaria Paula Foss
Maria Paula Foss
VTVitor Tumas
Vitor Tumas

26 October 2023 in The Clinical Neuropsychologist
Verified
Journal Article
Closed access
DFDiego Alves Ferreira
Diego Alves Ferreira
LMLorena Barbosa Cunha Macedo
Lorena Barbosa Cunha Macedo
MFMaria Paula Foss
Maria Paula Foss
Objective: Identifying neuropsychiatric symptoms (NPS) can aid in the early detection of Alzheimer's disease (AD); however, there is still a need for a greater consensus. This review aims to delineate the predominant NPS, compile a comprehensive list of the most commonly employed NPS assessment tools, and corroborate the principal findings regarding the link between NPS and neuropsychological assessment and neurobiological substrates. Methods: To conduct this scoping review, we followed the Preferred Reporting Items for Systematic Reviews guidelines and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). We searched for relevant articles published between 2017 and 2023 in MEDLINE, PsycINFO, PubMed, Web of Science, and Cochrane Library. Results: Of the 61 eligible articles, depression, anxiety, and apathy were the main NPSs. The Neuropsychiatric Inventory Questionnaire and Neuropsychiatric Inventory were the primary assessment tools used to evaluate NPS. Correlations between NPS severity and neurobiological markers were considered clinically significant. Furthermore, clinical procedures prioritized the use of global cognitive screening tools, assessments of executive functions, and functionality evaluations. Conclusion: Standardization of procedures is necessary because of the diversity of methods. The data show that NPS can predict the etiology, severity, form, and type of disease progression, serving as a precursor sign of AD. The results of the most common cognitive screening tools and NPS instruments provided an interesting overview of future clinical approaches.

25 June 2020 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
PDF file
MCMario Amore Cecchini
Mario Amore Cecchini
MFMaria Paula Foss
Maria Paula Foss
VTVitor Tumas
Vitor Tumas
FPFlávia A.P. Patrocinio
Flávia A.P. Patrocinio
RCRodolfo D. Chiari‐Correia
Rodolfo D. Chiari‐Correia
MYMônica Sanches Yassuda
Mônica Sanches Yassuda
Background: Short‐term memory binding (STMB) tests assess conjunctive binding, in which participants should remember the integration of features, such as shapes (or objects) and colors, forming a unique representation in memory. In this study, we investigated two STMB paradigms: change detection (CD) and free recall (FR).Objective: To investigate the cognitive profile in the CD and FR tasks of three diagnostic groups: cognitively unimpaired (CU), mild cognitive impairment (MCI), and Alzheimer's clinical syndrome (ACS). In addition, we aimed to calculate and compare the accuracy of the CD and FR tasks to identify MCI and ACS.Methods: Participants were 24 CU, 24 MCI, and 37 ACS. The cognitive scores of the clinical groups were compared using analysis of variance (ANOVA) and receiver‐operating characteristic (ROC) analyses were carried out to verify the accuracy of the STMB tasks.Results: In the CD task, CU was different from MCI and ACS (CU > MCI = ACS), while in the FR task all groups were different (CU > MCI > ACS). The ROC analyses showed an area under the curve (AUC) of 0.855 comparing CU with MCI for the CD task and 0.975 for the FR. The AUC comparing CU and ACS was 0.924 for the CD and 0.973 for the FR task. The FR task showed better accuracy to identify MCI patients, and the same accuracy to detect ACS.Conclusion: The present findings indicate that impairments in CD and FR of bound representations are features of the cognitive profiles of MCI and ACS patients.

1 December 2019 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
MFMaria Paula Foss
Maria Paula Foss
PDPaula Rejane Beserra Diniz
Paula Rejane Beserra Diniz
DRDaiane Leite da Roza
Daiane Leite da Roza
TGTamar Gefen
Tamar Gefen
AMAmanda Cook Maher
Amanda Cook Maher
ASAntônio Carlos Santos
Antônio Carlos Santos
The present study investigates cognitive performance and in vivo measures of brain volume in a single Brazilian cohort comprised of cognitively intact older adults with low and high educational levels, matched by age and gender. To better understand the impact of individual differences on the clinical manifestation of age-related dementia, this study examines proxies of brain reserve (i.e., structural anatomy) versus cognitive reserve (i.e., educational level and socioeconomic status) in a singlecohort of cognitively healthy elderly adults in Brazil.

1 January 2023 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
MAMaria Izaura Sedoguti Scudeler Agnollitto
Maria Izaura Sedoguti Scudeler Agnollitto
Renata F LeoniRenata F Leoni
Renata F Leoni
MFMaria Paula Foss
Maria Paula Foss
JPJulia Palaretti
Julia Palaretti
MCMarcela Cayres
Marcela Cayres
JMJulio Cesar Moriguti
Julio Cesar Moriguti
CBF measured with Arterial Spin Labeling (ASL) obtained by Magnetic Resonance Imaging (MRI) may become an important biomarker by showing changes in early stages of AD, such as in the prodromal stage of Mild Cognitive Impairment (MCI). Objective: Verify the correlation between atrophy and CBF in patients with MCI and mild phase ADD, to demonstrate whether changes in CBF can be considered as vascular biomarkers in the diagnosis of the DA continuum. Methods: 11 healthy volunteers, 16 MCI and 15 mild ADD were evaluated. Images of the brain were acquired, including CBF measured with Arterial Spin Labeling (ASL). Results: When comparing MCI with control, a reduction in normalized CBF was observed in left posterior cingulate (estimated difference -0.38; p=0.02), right posterior cingulate (estimated difference -0.45; p=0.02) and right precuneus (estimated difference -0.28; p <0.01); also increase in normalized CBF in right upper temporal pole (estimated difference 0.22; p=0.03). It was also observed that in MCI, the smaller the gray matter volume, the smaller the CBF in the left posterior cingulate; as well as the greater the cerebrospinal fluid volume, consequent to the encephalic volumetric reduction associated with atrophy, the greater the CBF in the right superior temporal pole. When comparing controls, MCI and mild AD, in relation to the other variables, no other correlations were observed between CBF and atrophy. Conclusion: In patients with MCI, the reduction of CBF in the left posterior cingulate correlated with gray matter atrophy, as well as the increase of CBF in the right upper temporal pole correlated with an increase in cerebrospinal fluid consequent to the encephalic volumetric reduction associated with atrophy, demonstrating the influence of CBF in AD related brain atrophy. These findings position CBF as a possible vascular biomarker for early-stage AD diagnoses.